Table 4.
PPI group 71 patients |
VPZ group 59 patients |
p | ||||||
---|---|---|---|---|---|---|---|---|
Tumor location | Body | 5/40 (13%) | 6/32 (19%) | 0.53 | ||||
Antrum | 4/31 (13%) | 11/27 (41%) | 0.06 | |||||
Number of tumors | Single | 6/53 (11%) | 9/40 (23%) | 0.22 | ||||
Multiple | 3/18 (17%) | 8/19 (42%) | 0.20 | |||||
Curability | Curative | 7/54 (13%) | 14/53 (26%) | 0.15 | ||||
Noncurative | 2/17 (12%) | 3/6 (50%) | 0.14 |
ESD: endoscopic submucosal dissection, VPZ: vonoprazan, PPI: proton-pump inhibitor